Subject(s)

COVID-19/complications , Herpes Simplex/complications , Herpesvirus 1, Human/isolation & purification , Massive Hepatic Necrosis/complications , Viremia/complications , Acyclovir/therapeutic use , Antiviral Agents/therapeutic use , COVID-19/pathology , COVID-19/therapy , Disease Management , Herpes Simplex/pathology , Herpes Simplex/therapy , Herpesvirus 1, Human/drug effects , Humans , Intensive Care Units , Male , Massive Hepatic Necrosis/pathology , Massive Hepatic Necrosis/therapy , Middle Aged , SARS-CoV-2/drug effects , SARS-CoV-2/isolation & purification , Severity of Illness Index , Viremia/pathology , Viremia/therapy

Subject(s)

Coronavirus Infections/complications , Pneumonia, Viral/complications , COVID-19 , Coronavirus Infections/epidemiology , Cytokine Release Syndrome/virology , Humans , Pandemics , Pneumonia, Viral/epidemiology